Open0.600 | Close- |
Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Open0.600 | Close- |
Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.220 | -0.0100 | ||||
REV | 4.870M | 2.679M | -2.191M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
OTLK | Outlook Therapeutics | 1.01% | 54.9M |
AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
CRIS | Curis | -4.32% | 50.7M |
INTS | Intensity Therapeutics | 8.15% | 54.5M |
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
There is no dividend information for HOOKIPA Pharma.
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Open0.600 | Close- |
Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.220 | -0.0100 | ||||
REV | 4.870M | 2.679M | -2.191M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
OTLK | Outlook Therapeutics | 1.01% | 54.9M |
AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
CRIS | Curis | -4.32% | 50.7M |
INTS | Intensity Therapeutics | 8.15% | 54.5M |
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
There is no dividend information for HOOKIPA Pharma.
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Open0.600 | Close- |
Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.220 | -0.0100 | ||||
REV | 4.870M | 2.679M | -2.191M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
OTLK | Outlook Therapeutics | 1.01% | 54.9M |
AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
CRIS | Curis | -4.32% | 50.7M |
INTS | Intensity Therapeutics | 8.15% | 54.5M |
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
There is no dividend information for HOOKIPA Pharma.
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Open0.600 | Close- |
Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.220 | -0.0100 | ||||
REV | 4.870M | 2.679M | -2.191M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
OTLK | Outlook Therapeutics | 1.01% | 54.9M |
AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
CRIS | Curis | -4.32% | 50.7M |
INTS | Intensity Therapeutics | 8.15% | 54.5M |
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
There is no dividend information for HOOKIPA Pharma.
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Open0.600 | Close- |
Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.220 | -0.0100 | ||||
REV | 4.870M | 2.679M | -2.191M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
OTLK | Outlook Therapeutics | 1.01% | 54.9M |
AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
CRIS | Curis | -4.32% | 50.7M |
INTS | Intensity Therapeutics | 8.15% | 54.5M |
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
There is no dividend information for HOOKIPA Pharma.
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Open0.600 | Close- |
Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.220 | -0.0100 | ||||
REV | 4.870M | 2.679M | -2.191M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
OTLK | Outlook Therapeutics | 1.01% | 54.9M |
AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
CRIS | Curis | -4.32% | 50.7M |
INTS | Intensity Therapeutics | 8.15% | 54.5M |
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
There is no dividend information for HOOKIPA Pharma.
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Open0.600 | Close- |
Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.220 | -0.0100 | ||||
REV | 4.870M | 2.679M | -2.191M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
OTLK | Outlook Therapeutics | 1.01% | 54.9M |
AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
CRIS | Curis | -4.32% | 50.7M |
INTS | Intensity Therapeutics | 8.15% | 54.5M |
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
There is no dividend information for HOOKIPA Pharma.
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Open0.600 | Close- |
Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.220 | -0.0100 | ||||
REV | 4.870M | 2.679M | -2.191M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
OTLK | Outlook Therapeutics | 1.01% | 54.9M |
AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
CRIS | Curis | -4.32% | 50.7M |
INTS | Intensity Therapeutics | 8.15% | 54.5M |
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
There is no dividend information for HOOKIPA Pharma.
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Open0.600 | Close- |
Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.220 | -0.0100 | ||||
REV | 4.870M | 2.679M | -2.191M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
OTLK | Outlook Therapeutics | 1.01% | 54.9M |
AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
CRIS | Curis | -4.32% | 50.7M |
INTS | Intensity Therapeutics | 8.15% | 54.5M |
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
There is no dividend information for HOOKIPA Pharma.
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.